Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

66.7%

4 terminated/withdrawn out of 6 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

2(33.3%)

Phase 1

2(33.3%)

Phase 3

2(33.3%)

6Total

Phase 2(2)

Phase 1(2)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07446881Phase 1Completed

A Phase 1 Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants.

Role: lead

NCT03831152Phase 3Withdrawn

Extension Study in Primary Distal Renal Tubular Acidosis

Role: lead

NCT04147871Phase 2Withdrawn

Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children

Role: lead

NCT03644706Phase 3Terminated

Study Evaluating Subjects With Distal Renal Tubular Acidosis

Role: lead

NCT04137978Phase 2Withdrawn

Study Evaluating Patients With Cystinuria

Role: lead

NCT03400189Phase 1Completed

Pharmacokinetics and Tolerability of Sulthiame

Role: collaborator

All 6 trials loaded